ATE145249T1 - Verfahren zur bestimmung von allelen für zystische fibrose - Google Patents

Verfahren zur bestimmung von allelen für zystische fibrose

Info

Publication number
ATE145249T1
ATE145249T1 AT90309420T AT90309420T ATE145249T1 AT E145249 T1 ATE145249 T1 AT E145249T1 AT 90309420 T AT90309420 T AT 90309420T AT 90309420 T AT90309420 T AT 90309420T AT E145249 T1 ATE145249 T1 AT E145249T1
Authority
AT
Austria
Prior art keywords
cystic fibrosis
determining alleles
alleles
determining
kits
Prior art date
Application number
AT90309420T
Other languages
English (en)
Inventor
Rakesh Anand
Alexander Fred Markham
John Craig Smith
Rashida Anwar
John Hamilton Riley
Donald James Ogilvie
Paul Elvin
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ATE145249T1 publication Critical patent/ATE145249T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855—Ligating adaptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
AT90309420T 1989-09-07 1990-08-29 Verfahren zur bestimmung von allelen für zystische fibrose ATE145249T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898920211A GB8920211D0 (en) 1989-09-07 1989-09-07 Diagnostic method

Publications (1)

Publication Number Publication Date
ATE145249T1 true ATE145249T1 (de) 1996-11-15

Family

ID=10662673

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90309420T ATE145249T1 (de) 1989-09-07 1990-08-29 Verfahren zur bestimmung von allelen für zystische fibrose

Country Status (10)

Country Link
US (1) US5939255A (de)
EP (1) EP0416801B1 (de)
AT (1) ATE145249T1 (de)
AU (1) AU649229B2 (de)
CA (1) CA2024769A1 (de)
DE (1) DE69029113T2 (de)
GB (2) GB8920211D0 (de)
IE (1) IE64396B1 (de)
NZ (1) NZ235159A (de)
ZA (1) ZA907013B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673986B1 (en) * 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
CA2086092A1 (en) * 1990-07-13 1992-01-14 Douglas A. Treco Library screening method
US5580734A (en) * 1990-07-13 1996-12-03 Transkaryotic Therapies, Inc. Method of producing a physical map contigous DNA sequences
FR2668162B1 (fr) * 1990-10-17 1993-01-22 Eurobio Lab Fragments d'adn, procede et coffret de diagnostic pour la detection des porteurs de la mutation delta-f-508 responsable de la mucoviscidose.
EP0511559A1 (de) * 1991-04-30 1992-11-04 F.Hoffmann-La Roche & Co. Aktiengesellschaft Reagens für eine Oligonukleotidprobe
NZ242955A (en) * 1991-06-13 1995-01-27 Ici Plc Dna containing gene sequences corresponding to sequences causing alzheimers disease, detection, recombinant yeast with such code
ATE205542T1 (de) 1992-03-04 2001-09-15 Univ California Vergleichende genomhybridisierung
US5976790A (en) 1992-03-04 1999-11-02 The Regents Of The University Of California Comparative Genomic Hybridization (CGH)
US7534567B2 (en) 1992-03-04 2009-05-19 The Regents Of The University Of California Detection of nucleic acid sequence differences by comparative genomic hybridization
DK0652975T3 (da) * 1992-07-31 2005-02-14 Garvan Inst Med Res Vurdering af allelvariation med hensyn til trans-virkende faktorer
WO1994006936A1 (en) * 1992-09-11 1994-03-31 Baylor College Of Medicine Method for the diagnosis of genetic disorders associated with chromosomal abnormalities and uniparental disomy
WO1998023733A2 (en) 1996-11-27 1998-06-04 University Of Washington Thermostable polymerases having altered fidelity
WO2005079474A2 (en) 2004-02-17 2005-09-01 The Regents Of The University Of California Detection of nucleic acid sequence differences by comparative genomic hybridization
EP1811832A4 (de) 2004-10-22 2009-12-30 Revivicor Inc Huftiere mit gentechnisch veränderten immunsystemen
CA2638904A1 (en) * 2006-01-20 2007-07-26 University Of South Florida Methods for profiling transcriptosomes
WO2010051288A1 (en) 2008-10-27 2010-05-06 Revivicor, Inc. Immunocompromised ungulates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293460C (en) * 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
EP0226288A3 (de) * 1985-10-09 1989-06-28 Collaborative Research Inc. Mittel und Verfahren zur Bestimmung von Cystic Fibrosis beruhend auf genetischer Kopplung
GB8709652D0 (en) * 1987-04-23 1987-05-28 Williamson R Diagnosis of cystic fibrosis
GB8818020D0 (en) * 1988-07-28 1988-09-01 Ici Plc Method for amplification of nucleotide sequences
US5240846A (en) * 1989-08-22 1993-08-31 The Regents Of The University Of Michigan Gene therapy vector for cystic fibrosis

Also Published As

Publication number Publication date
CA2024769A1 (en) 1991-03-08
DE69029113T2 (de) 1997-08-07
EP0416801A2 (de) 1991-03-13
GB8920211D0 (en) 1989-10-18
ZA907013B (en) 1992-05-27
IE903153A1 (en) 1991-03-13
DE69029113D1 (de) 1996-12-19
GB2235769A (en) 1991-03-13
GB2235769B (en) 1994-03-23
EP0416801B1 (de) 1996-11-13
AU6212790A (en) 1991-03-14
US5939255A (en) 1999-08-17
GB9018941D0 (en) 1990-10-17
AU649229B2 (en) 1994-05-19
NZ235159A (en) 1993-04-28
EP0416801A3 (en) 1991-09-18
IE64396B1 (en) 1995-08-09

Similar Documents

Publication Publication Date Title
DE69029113D1 (de) Verfahren zur Bestimmung von Allelen für zystische Fibrose
DE3850333D1 (de) Immobilisierte Elektrolytmembran und Verfahren zur Herstellung derselben.
ATE202801T1 (de) Verfahren zum nachweis, identifizieren und quantifizieren von organismen und viren
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
ATE90792T1 (de) Diagnostische verfahren zum nachweis von lymphomen bei menschen.
DE3778355D1 (de) Verfahren zur entkeimung von mit lebenden zellen umgebenen oberflaechen.
CY1108716T1 (el) Μεθοδος διαγνωσεως της νοσου του alzheimer με βαση μια μορφη μεταγραφης γονιδιου.
ATE49952T1 (de) Verfahren und vorrichtung zur herstellung von glasplatten.
ATE250671T1 (de) Verfahren mit einer hohen umsatzrate für das auffinden von sequenzen oder genetischen veränderungen in nukleinsäuren
ATE391175T1 (de) Multidrug resistenz gen
DE3882058D1 (de) Immunoreaktives reagens, verfahren zu seiner herstellung und seine verwendung zur bestimmung einer immunoreaktiven spezies.
DE3765150D1 (de) Testtraeger und verfahren zur bestimmung von gerinnungsparametern.
ATE2227T1 (de) Reagens zur lipasebestimmung und verfahren zu seiner herstellung.
DE3882723D1 (de) Verfahren zur herstellung von enzymelektroden.
DE3669591D1 (de) Verfahren und vorrichtung zur ermittlung der adhaesion von zellen.
DE69638123D1 (de) Für ein A. thaliana Protein kodierende DNA-Sequenz mit Delta-5,7-sterol-delta-7-Reduktaseaktivität, das Protein, Verfahren zur Herstellung, transformierte Hefe-Stämme und Verwendungen
DE3750779D1 (de) Enzym-Sensor und Verfahren zur Herstellung desselben.
EP0128018A3 (en) Molecular genetic probe, and method of forming same, assay technique and kit using said molecular genetic probe
DE3783773D1 (de) Vorrichtung zur feststellung der lebensfaehigkeit von nematoden und verfahren zu ihrer verwendung.
FI882800A7 (fi) Parannettu nukleiinihappohybridisaatiotekniikka ja testipakkaus.
DE3851304D1 (de) Verfahren und Testzusammensetzung zur Bestimmung von Enzym-Aktivität.
DE68922550D1 (de) Alkohol-oxidase Enzymelektrode und Verfahren zur Bestimmung von Alkoholeinhalt.
DE69019810D1 (de) Verfahren zur optischen Bestimmung von Bilirubin und Reagenz dafür.
DE3886450D1 (de) Aus Nukleinsäuren von menschlichen Papillomaviren bestehende Hybridisierungsproben und Methoden für deren Anwendung.
DE3851025D1 (de) Verfahren und Vorrichtung zur Bestimmung von zwei verschiedenen Substanzen in einer Probe unter Verwendung von Enzymelektroden.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties